Literature DB >> 20184566

Effect of chronic ethanol on enkephalin in the hypothalamus and extra-hypothalamic areas.

Guo-Qing Chang1, Jessica R Barson, Olga Karatayev, Si-Yi Chang, Yu-Wei Chen, Sarah F Leibowitz.   

Abstract

BACKGROUND: Ethanol may be consumed for reasons such as reward, anxiety reduction, or caloric content, and the opioid enkephalin (ENK) appears to be involved in many of these functions. Previous studies in Sprague-Dawley rats have demonstrated that ENK in the hypothalamic paraventricular nucleus (PVN) is stimulated by voluntary consumption of ethanol. This suggests that this opioid peptide may be involved in promoting the drinking of ethanol, consistent with our recent findings that PVN injections of ENK analogs stimulate ethanol intake. To broaden our understanding of how this peptide functions throughout the brain to promote ethanol intake, we measured, in rats trained to drink 9% ethanol, the expression of the ENK gene in additional brain areas outside the hypothalamus, namely, the ventral tegmental area (VTA), nucleus accumbens shell (NAcSh) and core (NAcC), medial prefrontal cortex (mPFC), and central nucleus of the amygdala (CeA).
METHODS: In the first experiment, the brains of rats chronically drinking 1 g/kg/d ethanol, 3 g/kg/d ethanol, or water were examined using real-time quantitative polymerase chain reaction (qRT-PCR). In the second experiment, a more detailed, anatomic analysis of changes in gene expression, in rats chronically drinking 3 g/kg/d ethanol compared to water, was performed using radiolabeled in situ hybridization (ISH). The third experiment employed digoxigenin-labeled ISH (DIG) to examine changes in the density of cells expressing ENK and, for comparison, dynorphin (DYN) in rats chronically drinking 3 g/kg/d ethanol versus water.
RESULTS: With qRT-PCR, the rats chronically drinking ethanol plus water compared to water alone showed significantly higher levels of ENK mRNA, not only in the PVN but also in the VTA, NAcSh, NAcC, and mPFC, although not in the CeA. Using radiolabeled ISH, levels of ENK mRNA in rats drinking ethanol were found to be elevated in all areas examined, including the CeA. The experiment using DIG confirmed this effect of ethanol, showing an increase in density of ENK-expressing cells in all areas studied. It additionally revealed a similar change in DYN mRNA in the PVN, mPFC, and CeA, although not in the NAcSh or NAcC.
CONCLUSIONS: While distinguishing the NAc as a site where ENK and DYN respond differentially, these findings lead us to propose that these opioids, in response to voluntary ethanol consumption, are generally elevated in extra-hypothalamic as well as hypothalamic areas, possibly to carry out specific area-related functions that, in turn, drive animals to further consume ethanol. These functions include calorie ingestion in the PVN, reward and motivation in the VTA and NAcSh, response-reinforcement learning in the NAcC, stress reduction in the CeA, and behavioral control in the mPFC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20184566      PMCID: PMC4467542          DOI: 10.1111/j.1530-0277.2010.01148.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  92 in total

1.  Selective reward deficit in mice lacking beta-endorphin and enkephalin.

Authors:  Michael D Hayward; John E Pintar; Malcolm J Low
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

Review 2.  Localization of drug reward mechanisms by intracranial injections.

Authors:  R A Wise; D C Hoffman
Journal:  Synapse       Date:  1992-03       Impact factor: 2.562

Review 3.  Overconsumption of dietary fat and alcohol: mechanisms involving lipids and hypothalamic peptides.

Authors:  Sarah F Leibowitz
Journal:  Physiol Behav       Date:  2007-03-30

4.  Effects of chronic food restriction on prodynorphin-derived peptides in rat brain regions.

Authors:  Y Berman; L Devi; K D Carr
Journal:  Brain Res       Date:  1994-11-21       Impact factor: 3.252

5.  Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Eur J Pharmacol       Date:  1985-09-10       Impact factor: 4.432

6.  A bi-directional mu-opioid-opioid connection between the nucleus of the accumbens shell and the central nucleus of the amygdala in the rat.

Authors:  Eun-Mee Kim; Joseph G Quinn; Allen S Levine; Eugene O'Hare
Journal:  Brain Res       Date:  2004-12-10       Impact factor: 3.252

7.  Central administration of an opiate antagonist decreases oral ethanol self-administration in rats.

Authors:  C J Heyser; A J Roberts; G Schulteis; G F Koob
Journal:  Alcohol Clin Exp Res       Date:  1999-09       Impact factor: 3.455

8.  Opioid effects on activation of neurons in the medial prefrontal cortex.

Authors:  J L Giacchino; S J Henriksen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1998-10       Impact factor: 5.067

9.  Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study.

Authors:  Minh P Lam; Peter W Marinelli; Li Bai; Christina Gianoulakis
Journal:  Psychopharmacology (Berl)       Date:  2008-08-08       Impact factor: 4.530

10.  Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on diet preference in a binge model of feeding.

Authors:  Amy M Naleid; Martha K Grace; Munya Chimukangara; Charles J Billington; Allen S Levine
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-04-11       Impact factor: 3.619

View more
  21 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  Neurochemical heterogeneity of rats predicted by different measures to be high ethanol consumers.

Authors:  Jessica R Barson; Shawn E Fagan; Guo-Qing Chang; Sarah F Leibowitz
Journal:  Alcohol Clin Exp Res       Date:  2012-06-22       Impact factor: 3.455

3.  Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats.

Authors:  Yan Zhou; Giancarlo Colombo; Gian Luigi Gessa; Mary Jeanne Kreek
Journal:  Neurosci Lett       Date:  2013-09-08       Impact factor: 3.046

Review 4.  Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  ILAR J       Date:  2012

Review 5.  Alcohol and basal ganglia circuitry: Animal models.

Authors:  David M Lovinger; Veronica A Alvarez
Journal:  Neuropharmacology       Date:  2017-03-21       Impact factor: 5.250

6.  Prenatal ethanol exposure stimulates neurogenesis in hypothalamic and limbic peptide systems: possible mechanism for offspring ethanol overconsumption.

Authors:  G-Q Chang; O Karatayev; S C Liang; J R Barson; S F Leibowitz
Journal:  Neuroscience       Date:  2012-06-26       Impact factor: 3.590

7.  Mu-opioid receptor activation in the medial shell of nucleus accumbens promotes alcohol consumption, self-administration and cue-induced reinstatement.

Authors:  Jocelyn M Richard; Howard L Fields
Journal:  Neuropharmacology       Date:  2016-04-14       Impact factor: 5.250

Review 8.  Hypothalamic neuropeptide signaling in alcohol addiction.

Authors:  Jessica R Barson; Sarah F Leibowitz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-14       Impact factor: 5.067

9.  Alcohol effects on synaptic transmission in periaqueductal gray dopamine neurons.

Authors:  Chia Li; Nora M McCall; Alberto J Lopez; Thomas L Kash
Journal:  Alcohol       Date:  2013-04-15       Impact factor: 2.405

10.  Hypothalamic injection of non-opioid peptides increases gene expression of the opioid enkephalin in hypothalamic and mesolimbic nuclei: Possible mechanism underlying their behavioral effects.

Authors:  Olga Karatayev; Jessica R Barson; Guo-Qing Chang; Sarah F Leibowitz
Journal:  Peptides       Date:  2009-09-24       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.